AusGo-SHEMO….Let’s Go! Australian Gold Standard Health Economics Model Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$378,959.00
Summary
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screening and treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may be squandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse, patient access to cost-effective medications may be delayed.
The Economics Of Surgery: Using Routine And Registry Data To Improve Policy, With Particular Reference To Congenital Heart Disease (the Fontan Procedure) And Prosthetic Surgery (hip And Knee Replacements)
Funder
National Health and Medical Research Council
Funding Amount
$86,073.00
Summary
My research will use economics to help improve surgery outcomes. Clinical and policy recommendations in surgery often come from a relatively low evidence base. I will make use of detailed data registries of previous recipients of hip and knee surgery (St. Vincent’s Hospital Melbourne) and Fontan heart surgery (Royal Children’s Hospital Melbourne) to develop advanced economic models of surgery outcomes. My aim is to use these models to improve real-world health policies in surgery.
Modelling The Cost-effectiveness Of Therapeutic Strategies For Invasive Candidiasis Among The ICU Population
Funder
National Health and Medical Research Council
Funding Amount
$282,733.00
Summary
ICU patients are vulnerable to fungal infections during their stay in hospital. These infections are costly to treat and pose real dangers to the patient with up to 1270 lives lost each year. The best way to diagnose and treat these infections is currently not known. Making an early and accurate diagnosis is difficult but important if the infection is to be managed appropriately. This research will show which management strategies are optimal for patients and health services.
Economic Evaluation Of Policies To Manage And Prevent Cardiovascular Disease & Diabetes In Australia
Funder
National Health and Medical Research Council
Funding Amount
$713,517.00
Summary
This Research Fellowship will use health economics to deliver health system impact. It will focus on: (i) mechanisms for setting prices for generic pharmaceuticals in Australia; (ii) exploring the implications for optimal prescribing from reductions in prices of pharmaceuticals to prevent cardiovascular disease and other chronic diseases; (iii) developing health economic computer simulation models to guide the prevention and treatment of diabetes and cardiovascular disease.
Development And Validation Of A Health Policy Simulation Model For Type 1 Diabetes.
Funder
National Health and Medical Research Council
Funding Amount
$409,199.00
Summary
This proposal brings together an international multi-disciplinary team to develop and validate a health economic computer simulation model for type 1 diabetes and its complications. It examines the impact of diabetes on costs as well as quality of life. Outcomes generated by the model will inform health policy decisions regarding allocation of resources for people with type 1 diabetes such as cost-effectiveness analysis of new treatments and technologies.
New Approaches To Describing And Valuing Quality Of Life
Funder
National Health and Medical Research Council
Funding Amount
$304,596.00
Summary
The ability of healthcare to improve quality of life is a major factor in determining public subsidy. This fellowship first explores patterns in Australian quality of life. This will identify groups with poor quality of life, and the remedying impact achieved under various interventions. It will then consider how people place value on aspects of quality of life. The two strands will allow linkage between important areas of quality of life and the policy impact of health interventions.
Economic Evaluation Of Alternative Pneumococcal Vaccination Strategies
Funder
National Health and Medical Research Council
Funding Amount
$242,894.00
Summary
Pneumococcal vaccination is a readily available preventive strategy that can offer substantial protection to the elderly but it is important that we carefully evaluate the different potential strategies to ensure the most (cost-) effective approach to prevention is identified. This grant will explore alternative strategies to control pneumococcal-related disease in elderly Australians using the available vaccines.
Developing An Australian Valuation For The EQ-5D-5L Quality Of Life Instrument
Funder
National Health and Medical Research Council
Funding Amount
$348,357.00
Summary
In the assessment of gains resulting from a health technology, it is standard to consider both mortality and quality of life effects. This project explores how Australians value different components of quality of life. To do this, we are running an online survey called a discrete choice experiment, and analysing the data using a range of cutting-edge econometric techniques. This will allow policy-makers to better reflect people's preferences when making decisions about new technologies.
Development And Validation Of A Health Policy Simulation Model For Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$507,910.00
Summary
The research is focused on evaluating policies associated with treating cardiovascular disease in Australia (CVD). It will involve the development of a computer simulation model for CVD which can be used to assess the cost-effectiveness of wide range of health care treatments. As prices of cardiovascular therapies after the expiry of patents, how much more widely should cardiovascular medication be prescribed? This is the type of question that can be answered through a CVD simulation model.
Increasing Population Health By Making Better Funding Decisions: Estimation Of The Cost-effectiveness Threshold For The Australian Health System
Funder
National Health and Medical Research Council
Funding Amount
$341,368.00
Summary
This project will estimate the Australian opportunity cost of decisions to fund new health care technologies, such as pharmaceuticals and medical devices. The opportunity cost represents the health benefits that could be achieved if the resources used to fund a new technology are used to fund the best alternative technology or service instead. We will then disseminate the information to decision makers, to improve funding decisions, and hence the efficiency of the Australian health care system.